Chronic Traumatic Encephalopathy

Chronic Traumatic Encephalopathy (CTE) is a progressive degenerative disease that occurs in individuals that suffer repetitive brain trauma. Discover the latest research on traumatic encephalopathy here.

August 17, 2020
Open Access

Anesthesia and the brain after concussion

Current Opinion in Anaesthesiology
Jeffrey J Pasternak, Arnoley S Abcejo
October 31, 2020
Open Access

Prion-Like Propagation Mechanisms in Tauopathies and Traumatic Brain Injury: Challenges and Prospects

Hadeel AlyenbaawiSue-Ann Mok
September 8, 2020

Health Forums and Twitter for Dementia Research: Opportunities and Considerations

Journal of the American Geriatrics Society
Nishila MehtaPaula A Rochon
December 7, 2020
Open Access

CCL2 is associated with microglia and macrophage recruitment in chronic traumatic encephalopathy

Journal of Neuroinflammation
Jonathan D CherryThor D Stein
December 10, 2020
Open Access

Chronic traumatic encephalopathy-a blueprint for the bridge between neurological and psychiatric disorders

Translational Psychiatry
Onder AlbayramRebekkah Mannix
September 30, 2020

Memory in repeat sports-related concussive injury and single-impact traumatic brain injury

Brain Injury : [BI]
Matthew J WrightJoaquín M Fuster
August 29, 2020
Open Access

Defining the Protein Seeds of Neurodegeneration using Real-Time Quaking-Induced Conversion Assays

Matteo Manca, Allison Kraus
August 28, 2020
Open Access

Risk for Misdiagnosing Chronic Traumatic Encephalopathy in Men With Anger Control Problems

Frontiers in Neurology
Grant L Iverson, Andrew J Gardner
September 11, 2020

Measuring stimulation and inhibition of intracellular nitric oxide production in SIM-A9 microglia using microfluidic single-cell analysis

Analytical Methods : Advancing Methods and Applications
Jay Sibbitts, Christopher T Culbertson
August 21, 2020
Open Access

The Role of Neuropsychiatric Symptoms in Research Diagnostic Criteria for Neurodegenerative Diseases

The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
Jeffrey Cummings
October 11, 2020
Open Access

Understanding the Cause of Chronic Traumatic Encephalopathy and Related Dementias

World Neurosurgery
Maryam Rezaeezadeh RoukerdGregory W J Hawryluk
December 18, 2020
Open Access

Alterations in Tau Metabolism in ALS and ALS-FTSD

Frontiers in Neurology
Michael J StrongKathryn Volkening
November 15, 2020

Long-Term Neurocognitive, Mental Health Consequences of Contact Sports

Clinics in Sports Medicine
Barry S WillerJohn Leddy
December 8, 2020
Open Access

Tau Filament Self-Assembly and Structure: Tau as a Therapeutic Target

Frontiers in Neurology
Sebastian S OakleyLouise C Serpell

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved